BioCorRx (BICX) Non Operating Income (2015 - 2026)
BioCorRx (BICX) posted Non Operating Income of $96108.0 for Q1 2026, up 52.63% sequentially from $62967.0 in Q4 2025, and up 11.52% YoY from $86182.0 in Q1 2025.
BioCorRx (BICX) Non Operating Income (2015 - 2026) Analysis & Trends
BioCorRx has reported Non Operating Income for 12 years, with the latest figure at $96108.0 in Q1 2026.
- Quarterly Non Operating Income rose 11.52% year-over-year to $96108.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 333.27% YoY) and the FY2025 annual result came in at $1.3 million, up 1576.48% from the prior year.
- Non Operating Income grew to $96108.0 in Q1 2026 per BICX's latest filing, from $62967.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $954000.0 in Q3 2025 and troughed at -$268771.0 in Q1 2024.
- A 5-year average of $87339.6 and a median of $62967.0 in 2025 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income surged 3807.1% in 2022, then sank 741.06% in 2023.
- Over 5 years, Non Operating Income stood at $22821.0 in 2022, then tumbled by 741.06% to -$146297.0 in 2023, then grew by 29.67% to -$102893.0 in 2024, then surged by 161.2% to $62967.0 in 2025, then jumped by 52.63% to $96108.0 in 2026.
- According to Business Quant data, Non Operating Income over the past three periods registered $96108.0, $62967.0, and $954000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 11.17 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | -3.49 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 3.91 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | -25.72 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96,108.00 |
| Dec 31, 2025 | 62,967.00 |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 36,644.00 |
| Mar 31, 2025 | 86,182.00 |
| Dec 31, 2024 | -102,893.00 |
| Sep 30, 2024 | 146,711.00 |
| Jun 30, 2024 | 135,356.00 |
| Mar 31, 2024 | -268,771.00 |
| Dec 31, 2023 | -146,297.00 |
| Sep 30, 2023 | 94,520.00 |
| Jun 30, 2023 | 23,354.00 |
| Mar 31, 2023 | 45,729.00 |
| Dec 31, 2022 | 22,821.00 |
| Sep 30, 2022 | 78,122.00 |
| Jun 30, 2022 | 40,537.00 |
| Mar 31, 2022 | 179,683.00 |
| Dec 31, 2021 | 131,403.00 |
| Sep 30, 2021 | 271,412.00 |
| Jun 30, 2021 | -98,499.00 |